New Class of Drugs Set to Treat Alzheimer’s, Parkinson’s
And Other Neurodegenerative Diseases

Also Appears Effective for Chronic Pain

Research from Brain Health Therapeutics has uncovered a remarkably effective combination of two FDA approved drugs.

Samples of healthy and diseased Neurons and Tau tangles that impair memory.

Samples of healthy and diseased Neurons and Tau tangles that impair memory.

The first plant-based drug slows the production of beta amyloid proteins thought to be a key contributor to the progression of Alzheimer’s disease. It has shown success in treating:

  • Neurodegenerative diseases: Alzheimer’s (AD), Parkinson’s (PD),
  • multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS)
  • Traumatic brain injury
  • Stroke
  • Epilepsy
  • Chronic pain
  • Cancer


However, this drug has significant drawbacks — impairments in long term cognitive function and synaptic plasticity. This has limited both the dosage and the use of the drug.


Careful research now shows that combining the plant-based drug with another inexpensive and common class of drugs stops the decrease in memory, cognitive abilities, and concentration.


Essential areas of the brain and what they are responsible for.


It allows the plant-based drug to work effectively while reducing or eliminating the negative side effects. This brings a new, potent treatment to neurodegenerative diseases and pain. It has the potential to address a host of other hard-to-treat diseases including: nausea from cancer treatments, PTSD, gastrointestinal ailments, migraine headaches, arthritis, asthma, and fibromyalgia.

Click here for more information about Brain Health’s technology